Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRACE trial of BCG vaccination for COVID-19 prevention in healthcare workers
NL-OMON55140Phase 3Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Aug 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) comparing BCG vaccine with Placebo saline (2 arms). Primary endpoints: Incidence of COVID-19 disease at 6 months and Incidence of severe COVID-19 disease at 6 months. Started Aug 2020; status: completed.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON55140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55140.